Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Revolution Medicines, Inc.

RVMD · Nasdaq · CIK 0001628171 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

139 Form 4 transaction lines observed in the same window
112 sales · 27 option, withholding, award, gift or other lines

Last qualifying purchase2024-12-05 · Schroeder Thilo · $60.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Mancini AnthonySee Remarks
○▼○▼▼○▼▼▼▼○▼
Horn Margaret AChief Operating Officer
○▼○▼○▼▼
Cislini JeffSVP & General Counsel
▼○▼▼▼
Anders JackChief Financial Officer
▼○▼▼
Kelsey Stephen MichaelSee Remarks
▼○▼▼
GOLDSMITH MARK ASee Remarks
▼○▼▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-12-05 · Schroeder Thilo.

Recent Form 4 activity

0Purchases
157Sales
52Other Form 4 lines
69SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING112 sale line(s) · context only
OTHER27 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
11,925,485
Previous report
9,669,157
Avg daily volume
2,564,736
Days to cover
4.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-12-05Schroeder ThiloPurchase (P)Common Stock1,304,347USD 46.00USD 59,999,962SEC filing ↗
2023-03-10Schroeder ThiloPurchase (P)Common Stock100,000USD 20.46USD 2,045,604SEC filing ↗
2023-03-07Schroeder ThiloPurchase (P)Common Stock550,000USD 22.00USD 12,100,000SEC filing ↗
2022-07-22Schroeder ThiloPurchase (P)Common Stock250,000USD 20.00USD 5,000,000SEC filing ↗
2022-07-22Kim Lorence H.Purchase (P)Common Stock50,000USD 20.00USD 1,000,000SEC filing ↗
2022-03-28Schroeder ThiloPurchase (P)Common Stock725USD 24.71USD 17,915SEC filing ↗
2022-03-25Schroeder ThiloPurchase (P)Common Stock42,000USD 24.79USD 1,041,333SEC filing ↗
2022-03-24Schroeder ThiloPurchase (P)Common Stock49,119USD 24.26USD 1,191,627SEC filing ↗
2022-03-23Schroeder ThiloPurchase (P)Common Stock53,118USD 23.72USD 1,259,972SEC filing ↗
2022-03-22Schroeder ThiloPurchase (P)Common Stock130,127USD 23.35USD 3,038,026SEC filing ↗
2022-03-21Schroeder ThiloPurchase (P)Common Stock75,731USD 20.74USD 1,570,334SEC filing ↗
2022-03-18Schroeder ThiloPurchase (P)Common Stock82,200USD 20.30USD 1,668,645SEC filing ↗
2022-03-17Schroeder ThiloPurchase (P)Common Stock10,120USD 18.78USD 190,054SEC filing ↗
2022-03-11Schroeder ThiloPurchase (P)Common Stock3,110USD 20.93USD 65,092SEC filing ↗
2022-03-10Schroeder ThiloPurchase (P)Common Stock40,400USD 20.61USD 832,671SEC filing ↗

Form 4 evidence

209 transaction lines in the latest 365-day window; 773 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-29Sandler Alan B.Sale (S)Common Stock6,309USD 202.14USD 1,275,294SEC filing ↗
2026-09-29Sandler Alan B.Option exercise / conversion (M)Common Stock6,000USD 58.84USD 353,040SEC filing ↗
2026-09-25Cislini JeffSale (S)Common Stock765USD 207.32USD 158,600SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-29Sandler Alan B.Sale (S)Common Stock6,309USD 202.14USD 1,275,294SEC filing ↗
2026-09-29Sandler Alan B.Option exercise / conversion (M)Common Stock6,000USD 58.84USD 353,040SEC filing ↗
2026-09-25Cislini JeffSale (S)Common Stock765USD 207.32USD 158,600SEC filing ↗
2026-09-25Mancini AnthonySale (S)Common Stock3,121USD 200.54USD 625,885SEC filing ↗
2026-09-25Mancini AnthonyOption exercise / conversion (M)Common Stock3,121USD 33.62USD 104,928SEC filing ↗
2026-09-24Mancini AnthonySale (S)Common Stock587USD 200.00USD 117,400SEC filing ↗
2026-09-22ANDERSON ELIZABETH MSale (S)Common Stock10,143USD 193.04USD 1,958,025SEC filing ↗
2026-09-22ANDERSON ELIZABETH MOption exercise / conversion (M)Common Stock5,070USD 1.12USD 5,678SEC filing ↗
2026-09-18Mancini AnthonySale (S)Common Stock1,764USD 196.94USD 347,402SEC filing ↗
2026-09-16Sandler Alan B.Sale (S)Common Stock341USD 199.24USD 67,940SEC filing ↗
2026-09-16Mancini AnthonySale (S)Common Stock1,774USD 199.24USD 353,443SEC filing ↗
2026-09-16Kelsey Stephen MichaelSale (S)Common Stock5,569USD 199.23USD 1,109,537SEC filing ↗
2026-09-16Horn Margaret ASale (S)Common Stock4,967USD 199.23USD 989,597SEC filing ↗
2026-09-16GOLDSMITH MARK ASale (S)Common Stock13,988USD 199.23USD 2,786,895SEC filing ↗
2026-09-16Cislini JeffSale (S)Common Stock3,366USD 199.23USD 670,621SEC filing ↗
2026-09-16Anders JackSale (S)Common Stock4,053USD 199.24USD 807,501SEC filing ↗
2026-09-11Kelsey Stephen MichaelSale (S)Common Stock92,531USD 202.36USD 18,724,677SEC filing ↗
2026-09-11Kelsey Stephen MichaelOption exercise / conversion (M)Common Stock92,531USD 41.71USD 3,859,488SEC filing ↗
2026-09-10Mancini AnthonySale (S)Common Stock15,448USD 204.16USD 3,153,800SEC filing ↗
2026-09-10Mancini AnthonyOption exercise / conversion (M)Common Stock9,363USD 33.62USD 314,784SEC filing ↗
2026-09-08Kim Lorence H.Sale (S)Common Stock17,090USD 209.82USD 3,585,811SEC filing ↗
2026-08-31Kim Lorence H.Sale (S)Common Stock56,000USD 203.24USD 11,381,290SEC filing ↗
2026-08-21GOLDSMITH MARK ASale (S)Common Stock86,000USD 209.20USD 17,991,043SEC filing ↗
2026-08-21GOLDSMITH MARK AOption exercise / conversion (M)Common Stock80,000USD 4.73USD 378,400SEC filing ↗
2026-08-21Cislini JeffSale (S)Common Stock56,894USD 209.24USD 11,904,274SEC filing ↗
2026-08-21Cislini JeffOption exercise / conversion (M)Common Stock56,280USD 20.00USD 1,125,687SEC filing ↗
2026-06-29Patel SushilSale (S)Common Stock5,580USD 187.99USD 1,048,976SEC filing ↗
2026-06-29Patel SushilOption exercise / conversion (M)Common Stock2,955USD 37.54USD 110,931SEC filing ↗
2026-06-24Anders JackSale (S)Common Stock20,000USD 168.33USD 3,366,643SEC filing ↗
2026-06-24Anders JackOption exercise / conversion (M)Common Stock20,000USD 18.56USD 371,200SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRVMD
CIK0001628171
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history773 transaction lines from 2020-02-18 to 2026-09-29
39 P purchase lines · 461 S sale lines · 273 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.